Literature DB >> 15994921

K-ras codon-specific mutations produce distinctive metabolic phenotypes in NIH3T3 mice [corrected] fibroblasts.

Pedro Vizan1, Laszlo G Boros, Agnes Figueras, Gabriel Capella, Ramon Mangues, Sara Bassilian, Shu Lim, Wai-Nang P Lee, Marta Cascante.   

Abstract

Among K-ras mutations, codon 12 mutations have been identified as those conferring a more aggressive phenotype. This aggressiveness is primarily associated with slow proliferation but greatly increased resistance to apoptosis. Using transfected NIH3T3 fibroblasts with a mutated K-ras minigene either at codon 12 (K12) or at codon 13 (K13), and taking advantage of [1,2-13C2]glucose tracer labeling, we show that codon 12 mutant K-ras (K12)-transformed cells exhibit greatly increased glycolysis with only a slight increase in activity along pathways that produce nucleic acid and lipid synthesis precursors in the oxidative branch of the pentose phosphate pathway and via pyruvate dehydrogenase flux. K13 mutants display a modest increase in anaerobic glycolysis associated with a large increase in oxidative pentose phosphate pathway activity and pyruvate dehydrogenase flux. The distinctive differences in metabolic profiles of K12 and K13 codon mutated cells indicate that a strong correlation exists between the flow of glucose carbons towards either increased anaerobic glycolysis, and resistance to apoptosis (K12), or increased macromolecule synthesis, rapid proliferation, and increased sensitivity to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994921     DOI: 10.1158/0008-5472.CAN-05-0074

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  54 in total

1.  KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).

Authors:  Harry H Yoon; David Tougeron; Qian Shi; Steven R Alberts; Michelle R Mahoney; Garth D Nelson; Suresh G Nair; Stephen N Thibodeau; Richard M Goldberg; Daniel J Sargent; Frank A Sinicrope
Journal:  Clin Cancer Res       Date:  2014-03-31       Impact factor: 12.531

2.  Cancer-associated isocitrate dehydrogenase 1 (IDH1) R132H mutation and d-2-hydroxyglutarate stimulate glutamine metabolism under hypoxia.

Authors:  Zachary J Reitman; Christopher G Duncan; Ethan Poteet; Ali Winters; Liang-Jun Yan; David M Gooden; Ivan Spasojevic; Laszlo G Boros; Shao-Hua Yang; Hai Yan
Journal:  J Biol Chem       Date:  2014-07-01       Impact factor: 5.157

3.  Ras Variant Biology and Contributions to Human Disease.

Authors:  Ian Prior
Journal:  Methods Mol Biol       Date:  2021

Review 4.  Famine versus feast: understanding the metabolism of tumors in vivo.

Authors:  Jared R Mayers; Matthew G Vander Heiden
Journal:  Trends Biochem Sci       Date:  2015-01-29       Impact factor: 13.807

Review 5.  Energy metabolism and proliferation in pancreatic carcinogenesis.

Authors:  Ivonne Regel; Bo Kong; Susanne Raulefs; Mert Erkan; Christoph W Michalski; Mark Hartel; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2012-03-20       Impact factor: 3.445

Review 6.  Roles of pyruvate carboxylase in human diseases: from diabetes to cancers and infection.

Authors:  Udom Lao-On; Paul V Attwood; Sarawut Jitrapakdee
Journal:  J Mol Med (Berl)       Date:  2018-01-23       Impact factor: 4.599

Review 7.  Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.

Authors:  Julian Swierczynski; Areta Hebanowska; Tomasz Sledzinski
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

8.  Block copolymer micelles for controlled delivery of glycolytic enzyme inhibitors.

Authors:  Shanjida Akter; Brian F Clem; Hyun Jin Lee; Jason Chesney; Younsoo Bae
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

9.  Anti-EGFR treatment effects on laryngeal cancer stem cells.

Authors:  Glaucia Maria de Mendonça Fernandes; Ana Lívia Silva Galbiatti-Dias; Leticia Antunes Muniz Ferreira; Vilson Serafim Junior; Gabriela Helena Rodrigues-Fleming; Juliana Garcia de Oliveira-Cucolo; Patrícia Matos Biselli-Chicote; Rosa Sayoko Kawasaki-Oyama; José Victor Maniglia; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

10.  Stable Isotope Resolved Metabolomics Analysis of Ribonucleotide and RNA Metabolism in Human Lung Cancer Cells.

Authors:  Teresa W-M Fan; Jinlian Tan; Martin M McKinney; Andrew N Lane
Journal:  Metabolomics       Date:  2012-06       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.